Bruno Gomes

Title: Bruno Gomes: Innovator in Cancer Treatment

Introduction

Bruno Gomes is a notable inventor based in Huningue, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the development of A2A inhibitors, which play a crucial role in cancer therapy.

Latest Patents

Bruno Gomes holds a patent for "2-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatment of cancers." This invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof. The invention further explores the use of these compounds as A2A inhibitors and their application in the treatment and/or prevention of cancer. Additionally, it includes a process for manufacturing these compounds.

Career Highlights

Throughout his career, Bruno Gomes has worked with prominent companies in the pharmaceutical industry, including Iteos Therapeutics and Iteos Belgium. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer treatments.

Collaborations

Bruno has collaborated with esteemed colleagues such as Stefano Crosignani and Erica Houthuys. These partnerships have enhanced his research efforts and fostered a collaborative environment for innovation.

Conclusion

Bruno Gomes is a dedicated inventor whose work in developing A2A inhibitors has the potential to significantly impact cancer treatment. His innovative approach and collaboration with industry professionals highlight his commitment to advancing medical science.